Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Metagenomi, Inc. - Common Stock (NQ: MGX ) 4.770 -0.410 (-7.92%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 30,107 Open 5.170 Bid (Size) 4.750 (1) Ask (Size) 5.480 (1) Prev. Close 5.180 Today's Range 4.640 - 5.370 52wk Range 3.340 - 12.74 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News METAGENOMI ALERT: Bragar Eagel & Squire, P.C. is Investigating Metagenomi, Inc. on Behalf of Metagenomi Stockholders and Encourages Investors to Contact the Firm July 18, 2024 From Bragar Eagel & Squire Via GlobeNewswire Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Metagenomi, Inc. (MGX) on Behalf of Investors July 18, 2024 From Glancy Prongay & Murray LLP Via Business Wire Performance YTD -53.73% -53.73% 1 Month +22.94% +22.94% 3 Month -38.45% -38.45% 6 Month -53.73% -53.73% 1 Year -53.73% -53.73% More News Read More Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Metagenomi, Inc. (MGX) July 17, 2024 From Kirby McInerney LLP Via Business Wire INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Metagenomi, Inc. (MGX) on Behalf of Investors July 17, 2024 From Law Offices of Howard G. Smith Via Business Wire The Law Offices of Frank R. Cruz Announces Investigation of Metagenomi, Inc. (MGX) on Behalf of Investors July 16, 2024 From Law Offices of Frank R. Cruz Via Business Wire Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference May 29, 2024 From Metagenomi, Inc. Via GlobeNewswire MGX Stock Earnings: Metagenomi Misses EPS, Beats Revenue for Q1 2024 May 14, 2024 Via InvestorPlace Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results May 14, 2024 From Metagenomi, Inc. Via GlobeNewswire Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula, Stock Soars May 02, 2024 Via Benzinga Exposures COVID-19 12 Health Care Stocks Moving In Thursday's Intraday Session May 02, 2024 Via Benzinga 3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire May 02, 2024 Via InvestorPlace Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems May 01, 2024 From Metagenomi, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session April 19, 2024 Via Benzinga Metagenomi to Present at Upcoming Scientific Meetings April 08, 2024 From Metagenomi, Inc. Via GlobeNewswire Metagenomi Reports Business Updates and Full Year 2023 Financial Results March 27, 2024 From Metagenomi, Inc. Via GlobeNewswire Metagenomi to Participate in the 44th Annual Cowen Healthcare Conference February 29, 2024 From Metagenomi Technologies, LLC Via GlobeNewswire This Biotech IPO Stock Just Took a Tumble, But Don't Give Up on It Yet February 19, 2024 Via The Motley Fool Topics Initial Public Offering Exposures Securities Market Metagenomi Announces Closing of Initial Public Offering February 13, 2024 From Metagenomi Technologies, LLC Via GlobeNewswire Gilead-Backed Kyverna Overshoots Raised IPO Expectations February 11, 2024 Via Talk Markets Topics Initial Public Offering Exposures Securities Market Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.